|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.454 USD | -27.18% |
|
-.--% | - |
| 07-20 | DOCMORRIS : UBS drops its Sell rating | ZD |
| 07-15 | Frankfurt stocks close: Dax slips by the narrowest margin below 25,000 points | DP |
Company Valuation: DocMorris AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,412 | 320.6 | 860.2 | 257.7 | 289.2 | 522.6 | - | - |
| Change | - | -86.71% | 168.32% | -70.05% | 12.22% | 80.73% | - | - |
| Enterprise Value (EV) 1 | 2,714 | 723.2 | 1,137 | 486.1 | 426.8 | 722.7 | 758.6 | 743.6 |
| Change | - | -73.36% | 57.22% | -57.25% | -12.21% | 69.35% | 4.96% | -1.98% |
| P/E | -10.1x | -1.61x | 10.5x | -2.42x | -1.71x | -6.82x | -13.7x | -38.2x |
| PBR | 5.44x | 0.84x | 2.01x | 0.69x | 0.7x | 1.64x | 1.65x | 1.82x |
| PEG | - | 0.1x | -0x | 0x | 0x | 0.1x | 0.3x | 0.6x |
| Capitalization / Revenue | 1.4x | 0.2x | 0.89x | 0.25x | 0.26x | 0.42x | 0.38x | 0.35x |
| EV / Revenue | 1.57x | 0.45x | 1.18x | 0.48x | 0.38x | 0.58x | 0.55x | 0.5x |
| EV / EBITDA | -19x | -9.31x | -29.6x | -10x | -8.85x | -42.5x | 35.8x | 14.4x |
| EV / EBIT | -14x | -5.15x | -13.7x | -5.41x | -4.41x | -11.2x | -24.7x | -231x |
| EV / FCF | -14x | -3.87x | -9.88x | -8.81x | -3.68x | -10.1x | -23.6x | -48.4x |
| FCF Yield | -7.15% | -25.9% | -10.1% | -11.4% | -27.2% | -9.86% | -4.23% | -2.07% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -23.4 | -15.88 | 7.05 | -8.25 | -3.47 | -1.567 | -0.7828 | -0.2795 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,726 | 1,608 | 966.9 | 1,017 | 1,124 | 1,237 | 1,389 | 1,485 |
| EBITDA 1 | -142.6 | -77.7 | -38.4 | -48.6 | -48.24 | -17 | 21.18 | 51.6 |
| EBIT 1 | -193.8 | -140.3 | -83.2 | -89.8 | -96.86 | -64.79 | -30.71 | -3.225 |
| Net income 1 | -225.7 | -171.1 | 82.2 | -97.3 | -134.4 | -81.01 | -43.68 | -22.4 |
| Net Debt 1 | 302.8 | 402.6 | 276.8 | 228.4 | 137.6 | 200.1 | 236 | 221 |
| Reference price 2 | 235.50 | 25.56 | 73.75 | 19.98 | 5.95 | 10.69 | 10.69 | 10.69 |
| Nbr of stocks (in thousands) | 10,240 | 12,543 | 11,664 | 12,897 | 48,599 | 48,889 | - | - |
| Announcement Date | 3/24/22 A | 3/24/23 A | 3/20/24 A | 3/12/25 A | 3/18/26 A | - | - | - |
1CHF in Million2CHF
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 17.84x | 0.75x | 11.77x | -.--% | 15.44B | |
| 23.37x | 0.93x | 16.39x | 0.97% | 7.07B | |
| 16.95x | 0.76x | 7.92x | 2.21% | 6.22B | |
| 14.21x | 0.91x | 6.6x | 3.02% | 4.02B | |
| 14.4x | 1.23x | 7.5x | 5.32% | 3.26B | |
| 14.45x | 0.6x | 4.77x | 4.78% | 3.17B | |
| 14.92x | 0.91x | 6.73x | 4.3% | 3.04B | |
| 40.84x | - | - | - | 2.65B | |
| Average | 19.62x | 0.87x | 8.81x | 2.94% | 5.61B | |
| Weighted average by Cap. | 18.94x | 0.83x | 10.27x | 1.85% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ROSE Stock
- ZRSEF Stock
- Valuation DocMorris AG
Select your edition
All financial news and data tailored to specific country editions
